Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion

D. T. Danahy, D. T. Burweld, W. S. Aronow, and R. Prakash. Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.Circulation 55:383–387 (1977).

C. V. Leier, D. F. Bambach, M. J. Thompson, S. M. Cattaneo, R. J. Goldberg, and D. V. Uneverferth. Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure.Am. J. Cardiol. 48:1115–1122 (1981).

A. Distante, A. Maseri, S. Severi, A. Biagini, and S. Chierchia. Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. A double crossover study in a coronary care unit.Am. J. Cardiol. 44:533–539 (1979).

S. J. Shane, J. J. Iazetta, A. W. Chisholm, J. F. Berka, and D. Leung. Plasma concentrations of isosorbide dinitrate and its metabolites after chronic oral dosage in man.Br. J. Clin. Pharmacol. 6:37–41 (1978).

M. G. Bogaert and M. T. Rosseel. Vascular effects of the dinitrate and mononitrate esters of isosorbide, isomannide and isoidide.Arch. Pharmacol. 275:339–342 (1972).

U. Abshagen and S. Sporl-Radon. First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.Eur. J. Clin. Pharmacol. 19:423–429 (1981).

Y. Santoni, P. H. Rolland, and J. P. Cano. Determination of isosorbide dinitrate and Its mononitrate metabolites in human plasma using Extrelut purification and capillary column GLC.J. Chromatogr. 306:165–172 (1984).

P. A. Cossum and M. S. Roberts. Availability of isosorbide dinitrate, diazepam and chlormethiazole from i.v. delivery systems.Eur. J. Clin. Pharmacol. 19:181–185 (1981).

T. Taylor, L. F. Chasseaud, E. Doyle, R. Bonn, A. Darrach, and R. F. Lambe. Isosorbide dinitrate pharmacokinetics.Arzneim. Forsch./Drug Res. 32:1329–1333 (1982).

H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).

T. Taylor, L. F. Chasseaud, and E. Doyle. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.Biopharm. Drug Dispos. 1:149–156 (1980).

R. Platzer, G. Reutemann, and R. L. Galeazzi. Pharmacokinetics of intravenous isosorbide dinitrate.J. Pharmacokin. Biopharm. 10:575–586 (1982).

A. Frydman, J. Levenson, A. Simon, M. Safar, A. Bieder, J. Bertharion, and J. Gaillot. Pharmacocinétique du dinitrate d'isosorbide. Approche après perfusion intraveineuse chez le patient hypertendu.Nouv. Presse Med. 11:2049–2056 (1982).

R. A. Morrison, U. W. Wiegand, E. Jahnchen, D. Hohmann, H. Bechtold, T. Meinertz, and H. L. Fung. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual and percutaneous dosing in angina.Clin. Pharmacol. Ther. 33:747–756 (1983).

H. Laufen, M. Aumann, and M. Leitold. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.Arzneim. Forsch./Drug Res. 33:980–984 (1983).

L. F. Chasseaud and T. Taylor. Pharmacokinetics of isosorbide mononitrates in human subjects. In Lichtenet al. (eds).,Nitrates III. Cardiovascular Effects, Springer, Berlin, 1981, pp. 47–53.

U. Abshagen, G. Betzien, R. Endele, and B. Kaufmann. Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate.Eur. J. Clin. Pharmacol. 20:269–275 (1981).

T. Taylor, L. F. Chasseaud, R. Major, E. Doyle, and A. Darragh. Isosorbide 5-mononitrate pharmacokinetics in humans.Biopharm. Drug Dispos. 2:255–263 (1981).

M. G. Bogaert. Clinical pharmacokinetics of organic nitrates.Clin. Pharmacokin. 8:410–421 (1983).

P. Sonneveld and J. A. Mulder. Development and identification of multicompartment model for the distribution of adriamycin in the rat.J. Pharmacokin. Biopharm. 9:577–601 (1981).

Y. Bard,Non-linear Parameter Estimation, Academic Press, New York, 1974, pp. 62–69.

L. B. Sheiner. Analysis of pharmacokinetic data using parametric models—1: Regression models.J. Pharmacokin. Biopharm. 12:93–117 (1984).

J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence, Hamilton, 1975.

R. L. Kashyap. Maximum likelihood identification of stochastic linear systems. IEEE Trans. Autom. Contr.AC-15:25–34 (1970).

A. Iliadis and R. Bruno. Maximum likelihood estimation of a non-linear multi-output pharmacokinetic model: The ethanol-acetate system. In G. C. Vansteenkiste and P. C. Young (eds.),Modelling and Data Analysis in Biotechnology and Medical Engineering, North-Holland, Amsterdam, 1983, pp. 189–197.

D. Goldfarb. A family of variable metric methods derived by variational means.Math. Comput. 24:23–26 (1970).